Papillary Tumor of the Pineal Region: A Distinct Molecular Entity

Papillary tumor of the pineal region (PTPR) is a neuroepithelial brain tumor, which might pose diagnostic difficulties and recurs often. Little is known about underlying molecular alterations. We therefore investigated chromosomal copy number alterations, DNA methylation patterns and mRNA expression...

Full description

Saved in:
Bibliographic Details
Published inBrain pathology (Zurich, Switzerland) Vol. 26; no. 2; pp. 199 - 205
Main Authors Heim, Stephanie, Sill, Martin, Jones, David T.W., Vasiljevic, Alexandre, Jouvet, Anne, Fèvre-Montange, Michelle, Wesseling, Pieter, Beschorner, Rudi, Mittelbronn, Michel, Kohlhof, Patricia, Hovestadt, Volker, Johann, Pascal, Kool, Marcel, Pajtler, Kristian W., Korshunov, Andrey, Ruland, Vincent, Sperveslage, Jan, Thomas, Christian, Witt, Hendrik, von Deimling, Andreas, Paulus, Werner, Pfister, Stefan M., Capper, David, Hasselblatt, Martin
Format Journal Article
LanguageEnglish
Published Switzerland Blackwell Publishing Ltd 01.03.2016
John Wiley & Sons, Inc
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Papillary tumor of the pineal region (PTPR) is a neuroepithelial brain tumor, which might pose diagnostic difficulties and recurs often. Little is known about underlying molecular alterations. We therefore investigated chromosomal copy number alterations, DNA methylation patterns and mRNA expression profiles in a series of 24 PTPRs. Losses of chromosome 10 were identified in all 13 PTPRs examined. Losses of chromosomes 3 and 22q (54%) as well as gains of chromosomes 8p (62%) and 12 (46%) were also common. DNA methylation profiling using Illumina 450k arrays reliably distinguished PTPR from ependymomas and pineal parenchymal tumors of intermediate differentiation. PTPR could be divided into two subgroups based on methylation pattern, PTPR group 2 showing higher global methylation and a tendency toward shorter progression‐free survival (P = 0.06). Genes overexpressed in PTPR as compared with ependymal tumors included SPDEF, known to be expressed in the rodent subcommissural organ. Notable SPDEF protein expression was encountered in 15/19 PTPRs as compared with only 2/36 ependymal tumors, 2/19 choroid plexus tumors and 0/23 samples of other central nervous system (CNS) tumor entities. In conclusion, PTPRs show typical chromosomal alterations as well as distinct DNA methylation and expression profiles, which might serve as useful diagnostic tools.
Bibliography:Figure S1. Differential methylation in PTPR subgroups. Table S1. Detailed patients' characteristics. Table S2. Methylation profiling. Table S3. Expression profiling.
Innovative Medizinische Forschung Münster - No. IMF HA 221211
ArticleID:BPA12282
German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO)
ark:/67375/WNG-X08V3JWJ-2
istex:EB3D1404D9BA878A54B4E06BBF737F69BFB62918
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ISSN:1015-6305
1750-3639
DOI:10.1111/bpa.12282